NSTI Announces More Than 50 Early Stage Company Reviews at Nanotech Ventures 2005 - Top Corporate and Private VC Firms Lead Vetting Teams
The Nano Science and Technology Institute (NSTI) today announced its Nanotech Ventures 2005 Conference to be held in Anaheim at the Anaheim Marriott Conference Center will exceed 50 early stage nanotech companies presenting at its annual Early Stage Review.
(PRWEB) April 21, 2005 -- Small technologies are rapidly maturing from lab to
marketplace. The Nanotech Ventures 2005 Early Stage Company Review provides an
ideal forum for "seed" to "early-stage" companies to showcase their
technologies, market advantages, and to search for funding. Companies are given
15 minutes to present and will have on-site feedback from Nanotech Ventures
Vetting Team. This years team includes representatives from such firms as: IBM,
Intel Capital, Mohr, Davidow Ventures, Burns Doane, DuPont Ventures,
ChevronTexaco Technology Ventures, Motorola Investments, Echelon Ventures,
Echelon Ventures, Wilmer Cutler Pickering Hale and Dorr, Harris and Harris
Group, Greenberg Traurig, 3i, UBS and Draper Fisher Jurvetson.
The goal
of the Early Stage event is to unite early stage public and pre-IPO
small-technology products and intellectual property (IP) with industrial users,
funding sources, technology providers and the media and analysts community. This
venue will be used to promote the commercial maturation across the
nanotechnology landscape, globally from technology to products.
The
format is a fast-paced event consisting of a 15-minute briefing covering the
products, target customers and business/licensing model for the presenting
company. This will be followed by a short review from members of the panel
including Q & A. Further one-on-one networking and business development
discussions are held in preset meeting areas.
Presenting companies are
clustered by focus and include: Healthcare with Inovatia Lab., Alpha-O Peptides,
3DM Inc., AptaSense, and Nano Interface Technology, Inc., presenting; Biotech
featuring Biophan Technologies, Inc., Cambridge Biomagnetics, CytImmune
Sciences, Inc., Midatech Limited, Nano S Biotechnologie, NanoBioMagnetics, Inc.,
NanoTechLogic Corporation, Nanotrope, Inc., Raustech Pty.Ltd., Russian
Biotechnologies and ViaLogy Corp.: Electronics will have Arccure technologies,
Nanometrix, Inc., NanoOpto Corporation, Nanopower Technologies, Inc., Optimer
Photonics, Inc. and XCom Wireless, Inc.; Materials includes presentations by
Advanced Diamond Technologies, Inc., Applied MicroStructures, Atomistix A/S,
Ceimig Ltd, ENSbio, Nanothinx and Solaris Nanosciences; Energy features Akermin,
Blu-Si, Collossus Nanotech and QuantumSphere; Sensors has Applied Standard,
BioNano Systems, Cantion A/S, CENTICE Corp., MET Tech and SENSIA presenting;
Instrumentation features Digital Matrix Corp, Focal Point Microsystems, Iatia
Ltd, Ionscope Limited, Molecular Imprints, Prodyne Corp. and Quantum Precision
Instruments.
Nanotech Ventures runs concurrently with Nanotech 2005, now
celebrating its 8th year, is the world’s largest nanotechnology conference of
its kind. The three-day conference provides over 60 sessions on business and
finance related to nanotechnology. The event also profiles new companies and
technologies and encourage business and scientific discussion among nanotech and
financial industry leaders.
To register for Nanotech Ventures or learn
more information, go to http://www.nsti.org/NanotechVentures2005/. For additional
information on sponsorship or exhibiting, please call (203)245-4201. Media
please contact Miranda Tan at 212-941-8499 or e-mail protected from spam bots
About NSTI
The NSTI provides analysis and information services for
government, business and industrial clients worldwide. The NSTI staff and vast
network of science advisors provide confidential technology and product review
services covering all domains of nano, bio, and micro technologies. For more
information, please contact e-mail protected from spam bots.
# # #
Source : http://www.prweb.com/releases/2005/4/prweb231298.htm